Companies across a variety of sectors related to health care weighed in Thursday after the U.S. Supreme Court upheld the Obama administration's health-care reform law, in one of the court's most highly anticipated decisions in years.
The ruling means different things to different sectors. Medicaid insurers, hospitals and diagnostic test makers stand to gain from the expanded coverage, while insurers and medical device companies are likely to face pressure from certain provisions.
Read the full story: http://tinyurl.com/6lku32c
Source: Morningstar
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Higher Oxidative Balance Score Linked to Lower Systemic Inflammation, Study Finds
August 5th 2025Researchers discovered a significant negative correlation between an individual's oxidative balance score and systemic immune-inflammation index, highlighting the role of antioxidants in reducing inflammation.
Read More
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More